A multimodal fusion system predicting survival benefits of immune checkpoint inhibitors in unresectable hepatocellular carcinoma

Abstract Early identification of unresectable hepatocellular carcinoma (HCC) patients who may benefit from immune checkpoint inhibitors (ICIs) is crucial for optimizing outcomes. Here, we developed a multimodal fusion (MMF) system integrating CT-derived deep learning features and clinical data to pr...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jun Xu, Tengfei Wang, Junjun Li, Yong Wang, Zhangxiang Zhu, Xiao Fu, Junjie Wang, Zhenglin Zhang, Wei Cai, Ruipeng Song, Changlong Hou, Li-Zhuang Yang, Hongzhi Wang, Stephen T. C. Wong, Hai Li
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Portfolio 2025-06-01
coleção:	npj Precision Oncology
Acesso em linha:	https://doi.org/10.1038/s41698-025-00979-6
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!